Soiken Holdings Inc. (2385.T)
JPY 128.0
(-0.78%)
JPY 128.0
(-0.78%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -4.79 Billion JPY | 19.44% |
| 2022 | -5.94 Billion JPY | 1.19% |
| 2021 | -6.01 Billion JPY | -41.39% |
| 2020 | -4.25 Billion JPY | 5.71% |
| 2019 | -4.51 Billion JPY | -45.54% |
| 2018 | -3.1 Billion JPY | -4.33% |
| 2017 | -2.97 Billion JPY | 9.59% |
| 2016 | -3.28 Billion JPY | -38.8% |
| 2015 | -2.36 Billion JPY | -19.3% |
| 2014 | -1.98 Billion JPY | -9.94% |
| 2013 | -1.8 Billion JPY | 13.23% |
| 2012 | -2.08 Billion JPY | -16.69% |
| 2011 | -1.78 Billion JPY | 5.97% |
| 2010 | -1.89 Billion JPY | -0.98% |
| 2009 | -1.87 Billion JPY | 16.4% |
| 2008 | -2.24 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | -4.7 Billion JPY | 7.02% |
| 2023 FY | -4.79 Billion JPY | 19.44% |
| 2023 Q3 | -4.93 Billion JPY | -4.86% |
| 2023 Q1 | -5.06 Billion JPY | 14.83% |
| 2023 Q4 | -4.79 Billion JPY | 2.99% |
| 2022 Q1 | -4.96 Billion JPY | 17.54% |
| 2022 FY | -5.94 Billion JPY | 1.19% |
| 2022 Q4 | -5.94 Billion JPY | -8.21% |
| 2022 Q3 | -5.49 Billion JPY | 0.68% |
| 2022 Q2 | -5.53 Billion JPY | -11.5% |
| 2021 Q2 | -5.33 Billion JPY | -26.59% |
| 2021 FY | -6.01 Billion JPY | -41.39% |
| 2021 Q1 | -4.21 Billion JPY | 0.97% |
| 2021 Q4 | -6.01 Billion JPY | -7.58% |
| 2021 Q3 | -5.59 Billion JPY | -4.84% |
| 2020 Q2 | -4 Billion JPY | -8.6% |
| 2020 Q3 | -4.79 Billion JPY | -19.87% |
| 2020 FY | -4.25 Billion JPY | 5.71% |
| 2020 Q1 | -3.68 Billion JPY | 18.32% |
| 2020 Q4 | -4.25 Billion JPY | 11.32% |
| 2019 Q4 | -4.51 Billion JPY | -24.38% |
| 2019 FY | -4.51 Billion JPY | -45.54% |
| 2019 Q1 | -2.49 Billion JPY | 19.54% |
| 2019 Q2 | -2.55 Billion JPY | -2.38% |
| 2019 Q3 | -3.62 Billion JPY | -42.04% |
| 2018 FY | -3.1 Billion JPY | -4.33% |
| 2018 Q2 | -2.69 Billion JPY | -1.44% |
| 2018 Q1 | -2.65 Billion JPY | 10.71% |
| 2018 Q4 | -3.1 Billion JPY | -21.43% |
| 2018 Q3 | -2.55 Billion JPY | 5.14% |
| 2017 FY | -2.97 Billion JPY | 9.59% |
| 2017 Q4 | -2.97 Billion JPY | -9.38% |
| 2017 Q3 | -2.71 Billion JPY | -9.28% |
| 2017 Q2 | -2.48 Billion JPY | 2.3% |
| 2017 Q1 | -2.54 Billion JPY | 22.58% |
| 2016 Q3 | -3.12 Billion JPY | -57.49% |
| 2016 FY | -3.28 Billion JPY | -38.8% |
| 2016 Q1 | -1.84 Billion JPY | 22.18% |
| 2016 Q2 | -1.98 Billion JPY | -7.67% |
| 2016 Q4 | -3.28 Billion JPY | -5.19% |
| 2015 FY | -2.36 Billion JPY | -19.3% |
| 2015 Q4 | -2.36 Billion JPY | -4.87% |
| 2015 Q3 | -2.25 Billion JPY | -41.59% |
| 2015 Q2 | -1.59 Billion JPY | -3.07% |
| 2015 Q1 | -1.54 Billion JPY | 22.05% |
| 2014 FY | -1.98 Billion JPY | -9.94% |
| 2014 Q3 | -1.86 Billion JPY | -23.67% |
| 2014 Q4 | -1.98 Billion JPY | -6.37% |
| 2014 Q2 | -1.5 Billion JPY | -2.32% |
| 2014 Q1 | -1.47 Billion JPY | 18.32% |
| 2013 Q1 | -1.71 Billion JPY | 17.65% |
| 2013 Q4 | -1.8 Billion JPY | -2.16% |
| 2013 Q3 | -1.76 Billion JPY | -1.88% |
| 2013 Q2 | -1.73 Billion JPY | -1.24% |
| 2013 FY | -1.8 Billion JPY | 13.23% |
| 2012 Q1 | -1.68 Billion JPY | 5.78% |
| 2012 Q3 | -1.9 Billion JPY | -3.16% |
| 2012 Q4 | -2.08 Billion JPY | -9.26% |
| 2012 Q2 | -1.84 Billion JPY | -9.89% |
| 2012 FY | -2.08 Billion JPY | -16.69% |
| 2011 FY | -1.78 Billion JPY | 5.97% |
| 2011 Q2 | -1.81 Billion JPY | 5.69% |
| 2011 Q1 | -1.92 Billion JPY | -1.29% |
| 2011 Q3 | -1.77 Billion JPY | 2.14% |
| 2011 Q4 | -1.78 Billion JPY | -0.58% |
| 2010 Q3 | -2.02 Billion JPY | -18.92% |
| 2010 FY | -1.89 Billion JPY | -0.98% |
| 2010 Q2 | -1.7 Billion JPY | 5.4% |
| 2010 Q4 | -1.89 Billion JPY | 6.52% |
| 2010 Q1 | -1.8 Billion JPY | 3.98% |
| 2009 Q2 | -2.07 Billion JPY | -2.15% |
| 2009 Q4 | -1.87 Billion JPY | 5.23% |
| 2009 Q3 | -1.98 Billion JPY | 4.33% |
| 2009 Q1 | -2.02 Billion JPY | 9.74% |
| 2009 FY | -1.87 Billion JPY | 16.4% |
| 2008 Q2 | -2.17 Billion JPY | 0.0% |
| 2008 FY | -2.24 Billion JPY | 0.0% |
| 2008 Q4 | -2.24 Billion JPY | -2.51% |
| 2008 Q3 | -2.19 Billion JPY | -0.68% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 742.75 Million JPY | 744.896% |
| PRISM BioLab Co.,LTD | -1.13 Billion JPY | -322.422% |
| GNI Group Ltd. | -17.93 Billion JPY | 73.29% |
| Linical Co., Ltd. | -4.46 Billion JPY | -7.32% |
| Trans Genic Inc. | -221.16 Million JPY | -2065.775% |
| MEDINET Co., Ltd. | -4.39 Billion JPY | -9.012% |
| Cytori Cell Research Institute, Inc. | 1.43 Billion JPY | 434.14% |
| AnGes, Inc. | -3.79 Billion JPY | -26.128% |
| OncoTherapy Science, Inc. | -420.8 Million JPY | -1038.295% |
| Nxera Pharma Co., Ltd. | 24.9 Billion JPY | 119.231% |
| Immuno-Biological Laboratories Co., Ltd. | -498.15 Million JPY | -861.555% |
| NanoCarrier Co., Ltd. | -466.34 Million JPY | -927.137% |
| Carna Biosciences, Inc. | -2.7 Billion JPY | -77.006% |
| CanBas Co., Ltd. | -1.88 Billion JPY | -153.682% |
| D. Western Therapeutics Institute, Inc. | -982.14 Million JPY | -387.712% |
| RaQualia Pharma Inc. | -3.39 Billion JPY | -41.007% |
| Chiome Bioscience Inc. | -1.03 Billion JPY | -363.004% |
| Kidswell Bio Corporation | 343.58 Million JPY | 1494.114% |
| PeptiDream Inc. | 3.29 Billion JPY | 245.505% |
| Oncolys BioPharma Inc. | -972.59 Million JPY | -392.5% |
| Ribomic Inc. | -2.09 Billion JPY | -128.124% |
| SanBio Company Limited | -3.78 Billion JPY | -26.395% |
| Healios K.K. | -2.19 Billion JPY | -118.723% |
| BrightPath Biotherapeutics Co., Ltd. | -944.85 Million JPY | -406.956% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -2.62 Billion JPY | -82.536% |
| Delta-Fly Pharma, Inc. | -1.41 Billion JPY | -238.025% |
| StemRIM | -8.41 Billion JPY | 43.044% |
| CellSource Co., Ltd. | -4.68 Billion JPY | -2.275% |
| FunPep Company Limited | -1.79 Billion JPY | -167.095% |
| Kringle Pharma, Inc. | -2.13 Billion JPY | -124.201% |
| Stella Pharma Corporation | -1.11 Billion JPY | -327.908% |
| TMS Co., Ltd. | -3.44 Billion JPY | -38.977% |
| Noile-Immune Biotech Inc. | -5.55 Billion JPY | 13.782% |
| Cuorips Inc. | -5.56 Billion JPY | 13.864% |
| K Pharma,Inc. | -3.26 Billion JPY | -46.645% |
| Takara Bio Inc. | -32.2 Billion JPY | 85.126% |
| ReproCELL Incorporated | -2.93 Billion JPY | -62.978% |
| PhoenixBio Co., Ltd. | -660.96 Million JPY | -624.707% |
| StemCell Institute Inc. | -2.83 Billion JPY | -68.856% |
| Japan Tissue Engineering Co., Ltd. | -2.06 Billion JPY | -131.812% |
| CellSeed Inc. | -2.01 Billion JPY | -138.068% |